KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Acquisitions (2016 - 2025)

Historic Acquisitions for AbbVie (ABBV) over the last 10 years, with Q1 2025 value amounting to $204.0 million.

  • AbbVie's Acquisitions fell 9778.24% to $204.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $204.0 million, marking a year-over-year decrease of 9883.38%. This contributed to the annual value of $17.5 billion for FY2024, which is N/A changed from last year.
  • Latest data reveals that AbbVie reported Acquisitions of $204.0 million as of Q1 2025, which was down 9778.24% from $8.3 billion recorded in Q3 2024.
  • Over the past 5 years, AbbVie's Acquisitions peaked at $9.2 billion during Q1 2024, and registered a low of $204.0 million during Q1 2025.
  • Its 3-year average for Acquisitions is $4.6 billion, with a median of $4.4 billion in 2021.
  • Its Acquisitions has fluctuated over the past 5 years, first soared by 33032.79% in 2021, then plummeted by 9778.24% in 2025.
  • Over the past 3 years, AbbVie's Acquisitions (Quarter) stood at $525.0 million in 2021, then skyrocketed by 1479.81% to $8.3 billion in 2024, then tumbled by 97.54% to $204.0 million in 2025.
  • Its Acquisitions was $204.0 million in Q1 2025, compared to $8.3 billion in Q3 2024 and $9.2 billion in Q1 2024.